EN 
EN
CN
AR
CS
FR
DE
IT
KO
PL
PT
RO
RU
ES
ID
VI
TRIf someone is ill, perhaps they wish to go to see the doctor. Testing to see what is happening into their body. This is a type of HONGAN hematology testing process which in turn assist the doctor to obtain clarity into a specific blood disorder, This kind of testing literally takes a sample of your blood to see how well each element is working.
Significance of point-of-care hematology testing
POCT is usually that just exactly where the physician operates a test and obtainsthe particular consequence there after. Since it could make, like when one is unwell and needs to understand what has offered him a difficult time his life span even before you blink your eye right? An excellent example is rapid blood tests in hematology. POCT Hematology Analyzers that allow doctors to get information about a patient's blood in less time than it would take if these tests went out to the laboratory and came back with results.
Quicker results can lead to better patient care
And because who will like to stay unwell, so it is common that you will look for a solution as soon possible. Hematology testing with HONGAN POCT can arm doctors with the information they need to make a proper diagnosis more rapidly. As a result, patients can start treatment sooner and begin to feel symptom relief. Patients are not only diagnosed faster, but they spend less time worrying about what is wrong with them. It means instead of being left without an alternative, they can find a solution sooner and start their path to recovery quickly.
POCT Hematology
Hematology testing before was when you have your blood drawn from a vein and put into a syringe or tube, then waiting for the results. Thus, the process is time-consuming and in the meantime patients will have to wait for results before any treatment can be suggested. POCT technology has allowed doctors to carry out Hematology analyzer at point of care in the hospital or doctor's office. It also implies that it offers an instant response to patients in most cases, within minutes. For patients who are in need of prompt treatment for their blood disorder, they need the fast turnaround.
Why POCT is Accelerating the Blood Disorder Diagnosing?
POCT technology improves the diagnosis of doctors for the blood infection. Doctors can also begin to identify which blood disorders have sparked the red flagWith the power to conduct a haematology test of any type right away, doctors will know just about everything there is to know concerning one patient´s blood. Using the AI-powered system could allow providers to identify illnesses sooner, and patients to receive treatment faster. Less trips to the doctor for patients with testing and follow-up POCT technology has reduced long hours of inability to diagnose and treat blood disorders in many traditional pathways.
POCT and its Impact on Hematology Results: Implications for Turnaround Times
The primary benefit of HONGAN hematology POCT is the significant reduction in turnaround time for test results. To be clear, in the past patients had to wait days, or longer for test results. While they waited to find out if indeed the had something like leukemia, surely they must have been living a bundle of nerves. Trade off with POCT is that the results will be known in minutes. For the patients and families, it alleviates some anxiety to know that progression could be rapid. That also means patients can be treated more quickly by doctors, which will result in better outcomes.
Conclusion
Point-of-care testing (POCT) remains an attractive and rewarding tool for providing optimal patient care with hematology being a challenging arena. In this context, DCN is one of the very few steps actually driven to streamline access for doctors to rapidly diagnose blood disorders and enhancing patient experience with a swift turn around time for results by using POCT technology. This would lead to quicker diagnoses, faster treatment times and imporved patient outcomes. We are a company that innovates with the aim of improving patient care, and shortening, simplifying and streamlining the testing process.
Established in July 2022, located in Lugu Chentai Science and Technology Park, High-tech Development Zone, Changsha City, Hunan Province, with approximately 5,000 square meters of R&D and production space. It is a medical device R&D and manufacturing company based on an AI intelligent platform. Focusing on primary medical technology, we aim to create a leading national inclusive medical device, persist in exploration and innovation, and continuously introduce ecological products and services.